CG Oncology, Inc.
CGON- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001991792
In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in CG Oncology, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 195
- +23 vs. Q3 2025
- Shares held
- 82.6M
- +5.05M (+6.5%) vs. Q3 2025
- Total value
- $3.43B
- +$305.4M (+9.8%) vs. Q3 2025
- New holders
- 43
- 72 more added
- Sold out
- 20
- 50 more reduced
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 227 | $6.66B |
| Q1 2026 | 233 | $6.03B |
| Q4 2025 | 195 | $3.43B |
| Q3 2025 | 176 | $3.13B |
| Q2 2025 | 163 | $1.97B |
| Q1 2025 | 142 | $1.74B |
| Q4 2024 | 140 | $1.90B |
| Q3 2024 | 121 | $1.96B |
| Q2 2024 | 111 | $1.37B |
| Q1 2024 | 96 | $1.70B |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding CG Oncology, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StemPoint Capital LP | 0 | $0 | 0.00% | −63,019−100.0% | Sold out |
| iA Global Asset Management Inc. | 0 | $0 | 0.00% | −48,660−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −20,850−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −15,273−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −13,224−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −12,437−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −6,995−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −6,932−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −6,132−100.0% | Sold out |
| Strengthening Families & Communities, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −343−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |